Agilon Health, Inc. (NYSE:AGL) Receives Average Rating of “Hold” from Analysts

Shares of Agilon Health, Inc. (NYSE:AGL) have been assigned a consensus recommendation of “Hold” from the nineteen ratings firms that are covering the company, MarketBeat reports. Two investment analysts have rated the stock with a sell rating, thirteen have given a hold rating and four have assigned a buy rating to the company. The average 1-year price objective among brokers that have issued a report on the stock in the last year is $2.8077.

A number of equities analysts recently issued reports on the company. Benchmark reduced their target price on Agilon Health from $4.00 to $1.50 and set a “buy” rating for the company in a research note on Wednesday, August 6th. Wells Fargo & Company reduced their price objective on Agilon Health from $5.00 to $1.50 and set an “overweight” rating for the company in a research note on Tuesday, October 7th. Jefferies Financial Group reduced their price objective on Agilon Health from $2.40 to $1.10 and set a “hold” rating for the company in a research note on Friday, August 15th. Robert W. Baird reduced their price objective on Agilon Health from $5.00 to $1.00 and set a “neutral” rating for the company in a research note on Thursday, August 14th. Finally, Barclays reduced their price objective on Agilon Health from $3.00 to $1.50 and set an “underweight” rating for the company in a research note on Wednesday, August 6th.

Hedge Funds Weigh In On Agilon Health

Institutional investors have recently modified their holdings of the stock. Arrowpoint Investment Partners Singapore Pte. Ltd. purchased a new position in shares of Agilon Health during the 2nd quarter valued at about $31,000. 111 Capital purchased a new position in shares of Agilon Health in the 2nd quarter valued at about $36,000. Nisa Investment Advisors LLC increased its stake in shares of Agilon Health by 244.9% in the 1st quarter. Nisa Investment Advisors LLC now owns 9,553 shares of the company’s stock valued at $41,000 after purchasing an additional 6,783 shares in the last quarter. Acropolis Investment Management LLC purchased a new position in shares of Agilon Health in the 2nd quarter valued at about $44,000. Finally, Gabelli Funds LLC purchased a new position in shares of Agilon Health in the 1st quarter valued at about $48,000.

Agilon Health Price Performance

Shares of AGL stock opened at $0.97 on Tuesday. The firm has a market capitalization of $400.33 million, a price-to-earnings ratio of -1.25 and a beta of 0.07. The business has a fifty day moving average of $1.12 and a 200 day moving average of $2.12. Agilon Health has a 1 year low of $0.71 and a 1 year high of $6.08.

Agilon Health (NYSE:AGL) last issued its earnings results on Monday, August 4th. The company reported ($0.25) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.11) by ($0.14). The firm had revenue of $1.39 billion during the quarter, compared to analysts’ expectations of $1.47 billion. Agilon Health had a negative return on equity of 66.76% and a negative net margin of 5.35%.The business’s revenue was down 5.9% on a year-over-year basis. During the same quarter last year, the business earned ($0.07) EPS. As a group, equities research analysts expect that Agilon Health will post -0.59 earnings per share for the current year.

About Agilon Health

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.